Hsbc Holdings PLC lowered its holdings in shares of Agilon Health, Inc. (NYSE:AGL – Free Report) by 19.7% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 106,704 shares of the company’s stock after selling 26,248 shares during the period. Hsbc Holdings PLC’s holdings in Agilon Health were worth $463,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently modified their holdings of the business. Millennium Management LLC raised its holdings in shares of Agilon Health by 187.8% during the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock worth $13,704,000 after buying an additional 4,706,357 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Agilon Health by 8.8% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,939,576 shares of the company’s stock worth $21,388,000 after purchasing an additional 398,027 shares in the last quarter. Nuveen LLC acquired a new position in Agilon Health in the 1st quarter worth about $17,242,000. Northern Trust Corp increased its holdings in Agilon Health by 13.0% in the 4th quarter. Northern Trust Corp now owns 2,962,350 shares of the company’s stock worth $5,628,000 after purchasing an additional 340,304 shares in the last quarter. Finally, Algert Global LLC increased its holdings in Agilon Health by 1,042.7% in the 4th quarter. Algert Global LLC now owns 2,108,687 shares of the company’s stock worth $4,007,000 after purchasing an additional 1,924,157 shares in the last quarter.
Agilon Health Trading Up 0.4%
Shares of AGL stock opened at $1.28 on Tuesday. The stock has a market cap of $528.39 million, a price-to-earnings ratio of -1.66 and a beta of 0.12. The stock has a 50-day moving average of $1.75 and a 200-day moving average of $2.89. Agilon Health, Inc. has a 1-year low of $0.71 and a 1-year high of $6.08.
Wall Street Analysts Forecast Growth
AGL has been the subject of a number of recent research reports. Evercore ISI lowered their target price on Agilon Health from $5.00 to $3.00 and set an “in-line” rating for the company in a report on Wednesday, July 9th. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $1.40 target price (down previously from $4.00) on shares of Agilon Health in a report on Wednesday, August 20th. The Goldman Sachs Group upped their target price on Agilon Health from $2.50 to $5.00 and gave the stock a “neutral” rating in a report on Thursday, May 8th. Jefferies Financial Group lowered their target price on Agilon Health from $2.40 to $1.10 and set a “hold” rating for the company in a report on Friday, August 15th. Finally, Robert W. Baird decreased their price target on Agilon Health from $5.00 to $1.00 and set a “neutral” rating for the company in a research note on Thursday, August 14th. Four research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Agilon Health currently has a consensus rating of “Hold” and a consensus price target of $3.07.
Agilon Health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
- Five stocks we like better than Agilon Health
- What is the S&P/TSX Index?
- 3 Healthcare Pathbreakers With Long-Term Tailwinds
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Tariff-Proof Retailers Making New All-time Highs
- How to Short a Stock in 5 Easy StepsĀ
- With Shares Near Highs, Here’s to Watch in Broadcom’s Q3 Report
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.